… These vary in the specific mutations that they detect, the amount of mutation they detect, the
… cost. Objectives: To compare the performance and cost-effectiveness of KRAS mutation tests …

… strategy, ie, that corresponding to the lowest cost per mutation detected, was found to be
a … Our results on genetic testing for breast cancer show that DS is not the most cost-effective …

… portion of the computational cost of mutation testing is incurred in executing mutants against
test cases, this cost can be reduced significantly by reducing the number of mutants to be …

… cost-effective for unselected genetic testing; from the societal perspective, 1% simulations
are cost-effective for testing … % simulations are cost-effective for unselected genetic testing. C …

… ‘EGFR testing strategy’, in which EGFR mutation testing was … mutations received gefitinib
while those without mutations … ‘no-testing strategy,’ in which genetic testing was not conducted …

… Given the effective options available for OC … cost-effective at 4% to 5% OC risk (15,16). This
enables clinical utility and supports implementation of clinical testing for these gene mutations…

… To compare the performance and cost-effectiveness of EGFR-TK mutation tests used to
identify previously untreated adults with locally advanced or metastatic NSCLC, who may benefit …

… determine the cost-effectiveness of EGFR mutation testing and first-line treatment with gefitinib
followed by second-line chemotherapy for patients who have activating EGFR mutations, …

… criteria are examined for their cost effectiveness and strength compared with mutation …
alternate mutations may serve as cost-effective alternatives to mutation testing in applications that …

… Our study shows population testing for BRCA1 mutations in SJ is extremely cost effective
compared with traditional FH-based testing and supports a paradigm change to population-…